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Abstract
A GGG GCC hexanucleotide repeat expansion within the C9orf72 gene is the most common genetic cause of both amyo-
trophic lateral sclerosis and frontotemporal dementia. Sense and antisense repeat-containing transcripts undergo repeat-
associated non-AUG-initiated translation to produce five dipeptide proteins (DPRs). The polyGR and polyPR DPRs are 
extremely toxic when expressed in Drosophila neurons. To determine the mechanism that mediates this toxicity, we purified 
DPRs from the Drosophila brain and used mass spectrometry to identify the in vivo neuronal DPR interactome. PolyGR and 
polyPR interact with ribosomal proteins, and inhibit translation in both human iPSC-derived motor neurons, and adult Dros-
ophila neurons. We next performed a screen of 81 translation-associated proteins in GGG GCC repeat-expressing Drosophila 
to determine whether this translational repression can be overcome and if this impacts neurodegeneration. Expression of the 
translation initiation factor eIF1A uniquely rescued DPR-induced toxicity in vivo, indicating that restoring translation is a 
potential therapeutic strategy. These data directly implicate translational repression in C9orf72 repeat-induced neurodegen-
eration and identify eIF1A as a novel modifier of C9orf72 repeat toxicity.
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Introduction
A GGG GCC hexanucleotide repeat expansion within the 
C9orf72 gene is the most common genetic cause of both 
amyotrophic lateral sclerosis (ALS) and frontotemporal 
dementia (FTD). Toxicity has been proposed to arise in 
patients either due to haploinsufficiency of the C9orf72 gene, 
or to two major gains of function mechanisms. These are the 
production of sense and antisense repeat RNA, leading to the 
formation of RNA-binding protein sequestering RNA foci, 
or the translation of the repeat RNA into highly repetitive 
dipeptide proteins [30]. Translation of repeat RNA occurs 
in the sense and antisense direction in an AUG-independent 
manner, known as repeat-associated non-AUG-initiated 
translation (RAN translation) [50], leading to the produc-
tion of five dipeptide proteins (DPRs): polyGP, polyGA and 
polyGR from the sense strand [1, 31], and polyGP, polyPA 
and polyPR from the antisense strand [12, 51].
Whether or not repeat RNA leads to toxicity in humans 
is currently contentious [30]. However, several groups, 
including our own, have previously demonstrated that 
expression of ATG-driven arginine-containing dipeptide 
proteins (polyGR, polyPR), which have been recodonised 
to lack a repetitive RNA intermediate, is extremely toxic to 
various model systems including human cell lines, Dros-
ophila and mice [18, 28, 43, 48], whilst polyGA exerts 
toxicity in some model systems [21, 26, 36, 49].
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The mechanisms by which the arginine-containing 
dipeptides are toxic is currently unresolved, with several 
theories posited including the induction of nucleolar dys-
function [18], binding to cellular RNAs [16], or disruption 
of nucleocytoplasmic transport [6, 10, 15, 46, 47] having 
been suggested as non-mutually exclusive mechanisms. 
Recently, several groups have published interactomes of 
DPR proteins derived from human cell lines and have com-
monly observed ribosomal proteins and RNA-binding pro-
teins as key constituents [5, 14, 16, 20, 22, 23, 45].
Here, we have identified proteins interacting with argi-
nine-containing DPRs in fly brains, by purifying dipeptide 
proteins directly from Drosophila neurons using tandem 
affinity purification coupled to mass spectrometry. Con-
sistent with previous results, we identified large numbers 
of ribosomal proteins binding to polyPR and polyGR, 
suggesting that translation may be impaired by the argi-
nine-rich DPRs. Consistently, we observed reduced trans-
lational activity in human induced pluripotent stem cell 
(iPSC)-derived motor neurons (MNs) overexpressing argi-
nine-rich DPR proteins, as well as in our in vivo Drosoph-
ila models expressing recodonised arginine-rich DPRs, or 
GGG GCC repeat RNA. To identify factors involved in pro-
tein translation that could rescue toxicity, we performed an 
extensive genetic screen of ribosomal proteins and transla-
tion initiation factors in our GGG GCC repeat Drosophila 
model. We identified a single translation-associated gene, 
the translation initiation factor eIF1A, as capable of rescu-
ing neuronal toxicity by enhancing translation. These find-
ings demonstrate that translational repression is a crucial 
toxic mechanism in an in vivo model system and identify 
a novel regulator of this process.
Materials and methods
Drosophila stocks and maintenance
Drosophila stocks were maintained on SYA food (15 g/L 
agar, 50  g/L sugar, 100  g/L autolysed yeast, 30  ml/L 
nipagin (10% in ethanol) and 3 ml/L propionic acid) at 
25 °C in a 12-h light/dark cycle with constant humidity. 
The elavGS stock was generously provided by Herve Tri-
coire (Paris Diderot University) [33]. The GMR-Gal4 line 
was obtained from the Bloomington Drosophila Stock 
Centre. UAS-GR50-FLAG, UAS-PR50-FLAG and UAS-
GA50-FLAG flies were kindly provided by Ludo Van Den 
Bosch (Vlaams Instituut voor Biotechnologie) [6]. The 
UAS-metRSL262G-EGFP line was described previously [9]. 
UAS-36R, UAS-GR100, and UAS-PR100 flies have been 
previously described [28]. The indicated overexpression 
lines were obtained from the FlyORF collection, including 
the UAS-eIF1A line (F001317) [4].
Generation of transgenic Drosophila
GA, GR and PR coding sequences were amplified with-
out their original 3′ stop codon from the original pUAST 
attb plasmids containing 200-aa dipeptide sequences 
(described in [28], using a common forward primer and 
a sequence-specific reverse primer. PCR products were 
digested and ligated into the GS-CTAP plasmid [19]. Vec-
tors were sequenced prior to injection into Drosophila. 
Repeat lengths were 199 amino acids for GR and GA, and 
179 amino acids for PR. Plasmids were injected by the 
University of Cambridge, Department of Genetics Fly 
Facility.
Assessment of eye phenotypes
Flies carrying UAS-dipeptide-GSTAP constructs were 
crossed to the GMR-GAL4 driver line. The resulting cross 
was allowed to develop and eclose at 25 °C; female eyes 
were photographed on the day of emergence.
Drosophila lifespan assays
The parental generation of the genotype indicated in each 
lifespan assay was allowed to lay for 24 h on grape agar 
plates supplemented with yeast. Eggs were deposited at 
a standard density into bottles containing SYA medium. 
Adult experimental flies were allowed to emerge and mate 
for 2 days before being lightly anaesthetised with  CO2, and 
females randomly allocated onto SYA containing RU486 
(200 μM) at a standard density per vial, with a minimum 
100 flies per condition. At regular intervals (see results), 
flies were tipped onto fresh food and dead flies counted. 
Escaping flies were censored from the data. Lifespans are 
presented as cumulative survival curves. Significance was 
assessed using the log rank test.
Tandem affinity purification of dipeptides
Experimental flies were bred as described for lifespans to 
generate the following genotypes: w; UAS-GR-GSTAP/+; 
elavGS/+w; UAS-GA-GSTAP/+; elavGS/+w; +; 
UAS-PR-GSTAP/elavGS.
Newly emerged flies were allowed to mate for 3–4 days 
before being tipped onto SYA medium containing 200 μM 
RU486 in bottles. Flies were left on RU486 for 3 days before 
being snap frozen in liquid nitrogen and stored at − 80 °C. 
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Tandem affinity purification was performed as previously 
described, with modifications [40]. Approximately 1 g of 
heads was ground in a mortar on dry ice before being trans-
ferred to a chilled 15 ml Dounce homogeniser and being 
homogenised using a loose pestle in ice cold 8 ml lysis buffer 
(50 mM Tris–HCl (pH 7.4), 125 mM NaCl, 5% glycerol, 
1.5 mM MgCl, 25 mM NaF, 0.2% IGEPAL, 1 mM  NaVO4, 
1 mM DTT, 1 mM EDTA). Homogenates were centrifuged 
at 21,000×g for 30 min at 4 °C, and supernatant was cen-
trifuged again under the same conditions. For each sample, 
400 μl of IgG Sepharose 6 Fast Flow beads (GE Health-
care) was washed three times in an excess IgG wash buffer 
(10 mM Tris–HCl (pH 8.0), 150 mM NaCl, 0.1% IGEPAL). 
Cleared homogenates were incubated with IgG Sepharose 
beads for 2 h at 4 °C with agitation. The homogenate and 
bead mixture was loaded onto a 15-ml econocolumn (Bio-
rad) at 4 °C. The homogenate was drained, and beads were 
washed three times with 10 ml of ice cold IgG wash buffer, 
before being washed once with 10 ml TEV cleavage buffer 
(10 mM Tris–Cl pH 8.0, 150 mM NaCl, 0.1% IGEPAL, 
0.5 mM EDTA, 1 mM DTT). Following this, TEV cleavage 
buffer containing 100 units/ml of AcTEV enzyme (Thermo 
Fisher Scientific) was applied, and beads were incubated in 
the column with agitation at 18 °C for 2 h.
240  μl of Streptavidin Agarose beads (Pierce) were 
washed three times in TEV cleavage buffer. The TEV 
cleavage product was incubated with the Streptavidin beads 
for 1.5 h at 4 °C. Beads were then washed once with TEV 
cleavage buffer, and then three times in TEV cleavage buffer 
without IGEPAL.
Beads were resuspended in 10 mM Tris–HCl pH 8.0, 
150 mM NaCl and split in two; each sample was resus-
pended in 10 mM Tris–HCl pH 8.0 and 150 mM NaCl with 
10 mM TCEP, and incubated at 37 °C for 10 min with shak-
ing. Beads were then pelleted and TCEP solution removed 
and replaced with 10 mM Tris–HCl pH 8.0, 150 mM NaCl 
with 20 mM iodoacetamide and incubated in the dark at 
room temperature for 30 min with shaking. Beads were 
pelleted and resuspended in 100 μl of 50 mM ammonium 
bicarbonate with 0.2 μg of sequencing-grade trypsin (Roche) 
(reconstituted in 0.5% formic acid) and digested overnight. 
After digestion, the beads were pelleted and the liberated 
peptides removed from the beads.
The peptide-containing supernatant was placed in a fresh 
Eppendorf tube, and the trypsin reaction was halted by the 
addition of 5% formic acid to a final concentration of 0.25%. 
To liberate residual peptide, beads were resuspended in 
100 µl of 1 M ammonium bicarbonate solution before being 
pelleted as before. Supernatant was removed, and 5% formic 
acid was added to a final concentration of 0.25%. For each 
sample, the original supernatant was pooled with the wash. 
Samples were frozen overnight at − 20 °C before being dried 
in a speed vacuum at 45 °C.
Mass spectrometry
All samples were filtered through in-house-made C8 tips 
(Empore Octyl C8, 3 M) to remove residual particulate material. 
Peptides were resuspended in 0.5% formic acid/100%  H2O before 
LC–MS/MS analysis on an Ultimate 3000 RSLCnano System 
coupled to a LTQ Orbitrap Velos hybrid mass spectrometer 
equipped with a nanospray source. The sample was first desalted 
on a PepMap C18 nano trap (100 μm i.d. × 20 mm, 100Å, 5 μm) 
at 10 μL/min for 15 min, then separated on a PepMap RSLC 
C18 column (75 μm i.d. × 250 mm, 100 Å, 2 μm) with a flow 
rate of 300 nl/min in a linear gradient of 4–32%  CH3CN/0.1% 
formic acid in 90 min, with total 130 min of acquisition time. The 
HPLC, columns and mass spectrometer were all from Thermo 
Fisher Scientific. The Orbitrap mass spectrometer was operated 
in the standard “top 15″ data-dependent acquisition mode while 
the preview mode was disabled. The MS full scan was set at m/z 
380–1600 with the resolution at 30,000 at m/z 400 and AGC at 
1 ×  106 with a maximum injection time at 200 ms. The siloxane 
ion at 445.120020 was used as lock mass. The 15 most abundant 
multiply charged precursor ions (z ≥ 2), with a minimal signal 
above 3000 counts, were dynamically selected for CID (collision 
induced dissociation) fragmentation in the ion trap, which had the 
AGC set at 5000 with the maximum injection timemat 100 ms. 
The precursor isolation width was set at 2 Da. The normalised 
collision energy for CID MS/MS was set at 35%. The dynamic 
exclusion duration time for selected ions for MS/MS was set for 
60 s with ± 10 ppm exclusion mass width.
The raw files were processed with Proteome Discoverer v1.4 
(Thermo). Database searches were performed with Mascot 
(Matrix Science) against the Drosophila Uniprot database (v. 
December 2015). The search parameters were: trypsin diges-
tion, two missed cleavages, 10 ppm mass tolerance for MS, 
0.5 Da mass tolerance for MS/MS, with variable modifications 
of carbamidomethyl (C), N-acetylation (protein), oxidation (M), 
and pyro-glu (NtermQ). Database search results were refined 
through Mascot Percolator (FDR < 1%). High-confidence pep-
tides were apportioned to proteins using Mascot Protein Fam-
ily summary. Protein identification required at least one high-
confidence peptide (FDR < 1%) and a minimum Mascot protein 
score of 20. External contaminants were removed for further 
analysis. The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium via the PRIDE 
[41] partner repository with the dataset identifier PXD012099 .
FUNCAT 
To ensure equivalent baseline translation, repeat inser-
tions were backcrossed for six generations into the w1118 
background. The elavGS driver and the UAS-metRSL262G-
EGFP insertion were recombined onto the same chromo-
some, and UAS-repeat stocks or w1118 crossed to this stock. 
Adult females were split into vials containing SYA media 
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supplemented with 200 μM RU486. 3 days after induction, 
flies were briefly anaesthetized using  CO2 and injected into 
the haemolymph with 32.2 nl of 200 mM of azidonorleu-
cine (ANL) solution made in sterile PBS (pH7.4) or vehicle 
alone. Flies were allowed to recover for 48 h on food sup-
plemented with RU486 before adult brains were dissected 
in haemolymph-like solution with calcium, and fixed and 
processed in the manner described previously [9]. Following 
the FUNCAT procedure, brains were mounted in vectashield 
with DAPI (Vectorlabs). Images of neurons were taken using 
a Zeiss LSM 710 confocal microscope with the 63× objec-
tive lens. An image was taken in the optic lobe of each brain, 
three boxes of equal size were drawn in different regions of 
the tissue using the GFP channel as a guide, and TAMRA 
intensity measured using imageJ image analysis software, 
GFP intensity and TAMRA intensity were averaged across 
the three regions. Experimenter was blinded to genotype 
during image acquisition and analysis.
Generation of GFP‑tagged DPR and FLAG‑EIF1AX 
plasmids
Previously described 200-aa-encoding dipeptide repeat 
sequences (GA100, PR100, and GR100) [28] were sub-
cloned into the PCDNA3.1(+) vector using BamHI and NotI 
restriction sites. Following this, the GFP coding sequence 
was liberated from the pEGFP-C3 vector (Addgene 6082-1) 
using the BglII and BmtI restriction sites, and was subcloned 
N-terminally to the dipeptide coding sequence by digest-
ing the PCDNA3.1(+)-DPR vector with BamHI and BmtI. 
Human EIF1AX coding sequence was generated by gene 
synthesis (GeneArt) inserted into the PCDNA3.1(+) plas-
mid and an N-terminal FLAG tag added by PCR.
Cell culture and AHA staining
For iPSC culture, an iPSC line from a healthy donor was 
maintained in Essential  E8™ medium cultured on Getrex-
coated plates. The control iPSC line has been used in previ-
ous study described as ‘Control 1′, the healthy donor was 
male and 64 years old at time of biopsy [38]. iPSCs were 
grown to full confluence and then induced into motor neu-
ron-like cells as previously described [13, 38]. Briefly, after 
the patterning stage, at day 18 of differentiation, progenitor 
MNs were expanded in neuronal medium containing FGF 
(10 ng/µl).
Progenitor MNs were cultured with additional 10 µM, 
Y-27632 dihydrochloride (ROCK inhibitor), for 1 h prior to 
nucleofection. Cells were lifted into suspension after incuba-
tion for 5 min at 37 °C with 0.5 mM EDTA in 1× PBS. 2 × 
 106 cells per condition were centrifuged at 300×g for 5 min. 
Cell pellet was gently resuspended in 100 µl of Basic Neu-
ron  Nucleofector™ solution (Lonza). 4 µg of plasmid DNA 
was added before the mixture was transferred into cuvette 
and electroporated using Amaxa™ Nucleofector™ II device 
and programme A-033. Immediately afterwards, the mix was 
added to pre-warmed neuronal medium containing 0.1 µM 
Compound E (Merk, 565790) and 10 µM ROCK inhibi-
tor. Cells were then plated onto coverslips pre-coated with 
Geltrex™.
24  h after nucleofection cells were placed in neu-
ronal methionine-free medium for 30 min, made by sup-
plementing DMEM–l-methionine–l-cysteine  (Gibco™ 
21013024) with 0.23 mM sodium pyruvate, 10 mM HEPES, 
0.26 mM l-cysteine, 0.067 mM l-proline, 0.674 µM zinc sul-
phate, 5 nM B12, non-essential amino acids 0.5% (Gibco), 
Glutamax 1%, 5 µg/ml insulin, B27 supplement (1×) and 
N2 supplement (1×). Cells to be used as negative control 
had neuronal methionine-free medium supplemented with 
50 µM anisomycin. Cells were then cultured with 150 µM 
Click-iT® AHA (L-azidohomoalanine) (Thermo Fisher), in 
neuronal methionine-free medium for 2 h. Negative controls 
had 150 µM Click-iT® AHA and additional 100 µM ani-
somycin. Cells were fixed and stained with Click-iT® Cell 
Reaction Buffer Kit (Cat. no. C10269) and the fluorophore 
Alexa 555 alkyne (1 µM).
HeLa cells were maintained in DMEM complete medium 
(10% FBS, 1% Glutamax, 1% sodium pyruvate, 1% Pen/
Strep) and plated on coverslips in 24-well plates the day 
before transfection. Cells were transfected with either GFP 
alone (320 ng), GFP-GR100 (80 ng) together with FLAG-
EIF1AX (240 ng), or GFP-GR100 (80 ng) together with 
FLAG alone (240 ng), using Lipofectamine 2000. After 
24 h, the medium was changed to methionine-free DMEM 
for 30 min before the addition of AHA as described above 
for MN progenitors. Cells were stained with anti-FLAG anti-
body (F1804, Sigma) prior to imaging.
A confocal microscope (Zeiss LSM 710 for MN pro-
genitors, Zeiss LSM 880 for HeLa cells) was used to take Z 
stacks and maximum intensity projection images were ana-
lysed using ImageJ to quantify the intensity of AHA staining 
(Alexa 555) in cells positive for GFP or GFP-tagged DPRs.
Drosophila polyGR ELISA assay
Heads from female flies induced on SYA medium containing 
200 μM RU486 for 7 days were collected and processed in 
the manner described previously [29].
Quantitative reverse transcription PCR (RT‑qPCR)
Female flies were induced on SYA medium containing 
200 μM RU486 for 5 days before being flash frozen in liq-
uid nitrogen. 9–10 heads per replicate were extracted using 
TRIzol reagent (Thermo Fisher Scientific) following manu-
facturer’s protocol. 1 μg of RNA per sample was treated 
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with DNase I (Ambion), followed by reverse transcription 
using the SuperScript II system (Invitrogen) using random 
hexamers (Thermo Fisher Scientific). Quantitative PCR was 
performed using the QuantStudio 6 Flex Real-Time PCR 
System (Applied Biosystems) using  SYBR® Green master 
mix (Applied Biosystems). Values were obtained using the 
relative standard curve method and normalised to alpha-
Tub84B. Primers used were: EGFP forward: GGT GAA CTT 
CAA GAT CCG CC; EGFP reverse: CTT GTA CAG CTC GTC 
CAT GC; Tub84B forward: TGG GCC CGT CTG GAC CAC 
AA; Tub84B reverse: TCG CCG TCA CCG GAG TCC AT.
Bioinformatics
The string network was created by uploading GR and PR-
interacting proteins to the STRING web interface [39], and 
the resultant image was created using Cytoscape. Gene 
ontology analysis was performed using WebGestalt [42].
To assess overlap of mass spectrometric data sets, data 
sets were downloaded from supplementary material of 
the referenced original papers: from Lee et al. (2016) [20] 
GR and PR interactors with a Saint cutoff of > 0.9 were 
taken; from Lin et al. [22] the PR interactome common to 
both methods was used; for Boeynaems et al. [5] the PFA 
crosslinked data set was used; for Lopez-Gonzalez et al. 
[23] the non-RNAse-treated data set was used; the Yin 
et al. [45] dataset was used, with removal of the ten pro-
teins not included in the analysis performed in the original 
study. Genes were converted to Drosophila orthologs using 
BioMart (Ensembl), and significance of overlap performed 
in comparison with the hypergeometric distribution in R 
based on an estimated Drosophila protein-coding genome 
size of 13,931 genes. The six-way overlap between the data 
sets was created using jVenn [2].
Drosophila screen
Flies carrying UAS-ribosomal and initiation factor protein 
transgenes inserted at the attP-86Fb integration site were 
ordered from the FlyORF stock repository and crossed to vir-
gin females carrying the UAS-36R and elavGS transgenes. 
The attP-86Fb injection strain was crossed as the control. 
Emerging adult flies were allowed to mate for 24 h, before 
100 flies of each genotype were split at a density of 25 flies 
per vial on SYA supplemented with 200 μM RU486. Flies 
were scored until days 12–13 (approximately 30–40% con-
trol flies had died) and mortality of each line scored as a 
percentage of controls. Transgenes leading to less than 30% 
death, relative to the control, were rescreened using a similar 
protocol. If the same effect was observed, transgenes were 
backcrossed for six generations in to the w1118 background 
and retested.
Results
Characterisation of arginine‑rich DPR interactome 
in vivo in Drosophila neurons
To determine which proteins the arginine-containing DPRs 
form complexes with in an intact neuronal system, DNA 
sequences encoding recodonised ATG-driven dipeptide pro-
teins [28] were cloned upstream of a tandem affinity purifi-
cation (TAP) tag containing a protein G module and strepta-
vidin-binding domain separated by an internal tobacco etch 
virus (TEV) protease cleavage site (GSTAP tag). We gener-
ated Drosophila capable of expressing 90–100 repeats of the 
following DPRs: polyGR, polyPR and polyGA. After gen-
eration of transgenic Drosophila, constructs were expressed 
in the developing compound eye using the GMR-Gal4 driver 
and, as expected, strong toxicity was observed for the GR-
GSTAP and PR-GSTAP constructs but not the GA-GSTAP 
control construct (Suppl. Figure 1a, Online Resource 1). 
We confirmed expression of the GSTAP-tagged constructs 
using the elavGS driver which drives expression in adult 
neurons, observing a robust expression of polyGA and a 
weaker expression of polyGR and polyPR (Suppl. Figure 1b, 
Online Resource 1).
We performed tandem affinity purification coupled to 
LC–MS/MS to identify dipeptide-interacting proteins in 
adult Drosophila neurons, performing three independent 
replicates and including only data present in ≥ 2/3 replicates. 
We used polyGA as a negative control, filtering the results 
to exclude polyGA-interacting proteins, as these probably 
represent proteins that bind to the TAP tag itself, or proteins 
that are unlikely to play a role in arginine-rich DPR toxic-
ity in Drosophila. In total, we identified 94 proteins that 
bind to either polyPR or polyGR, with 82 specific to polyPR 
alone, 5 specific to polyGR alone, and 7 common between 
both proteins (Fig. 1a). The higher number of interactors in 
the polyPR data set was consistent across replicates (Suppl. 
Table 1, Online Resource 2), suggesting that polyPR may 
bind to protein complexes with a higher degree of avidity, 
or may be expressed at a higher level/undergo less clearance 
compared to polyGR. 49 proteins were found to overlap with 
both polyGA and polyPR and/or polyGR (Suppl. Figure 2, 
Online Resource 1), which are likely to have interacted with 
the epitope tag. Two proteins were found to be specific to 
GA, including unc-119, which has previously been dem-
onstrated to be a key GA-interacting protein in transfected 
cells and forms aggregates in C9orf72 human post-mortem 
tissue [26, 37].
Several recent studies have performed mass spectrom-
etry on PR- or GR-interacting proteins using lysates from 
immortalised non-neuronal cell lines [5, 16, 20, 22, 23, 45]. 
To determine whether these shared common interactors with 
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our dataset, where a complete list of interactors was avail-
able, we converted the identified human genes into Dros-
ophila orthologs, and analysed the degree of overlap, finding 
a highly significant overlap with each data set (Suppl. Fig-
ure 3, Online Resource 1). We performed STRING analysis 
to cluster the Drosophila-interacting proteins into a network, 
and observed a strong enrichment of ribosomal proteins in 
the Drosophila data set (Fig. 1b). When gene ontology anal-
ysis was performed on the total set of interacting proteins, 
the most significantly overrepresented ontology term was 
“cytoplasmic translation” (P < 1E−10). Notably, this was 
consistent with the human data set, where of the orthologous 
shared interactors present in all six data sets (five human 
cell line and one Drosophila neuron), 100% were ribosomal 
proteins, with both small and large ribosomal subunits rep-
resented (Suppl. Figure 4, Online Resource 1).
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Fig. 1  Arginine-rich DPRs bind to ribosomal proteins and proteins 
involved in translation. a Results of mass spectrometric identification 
of polyGR- and polyPR-interacting proteins in vivo. Numbers repre-
sent individual proteins identified in a minimum of 2/3 replicates. A 
consistently larger number of interactors were identified as binding 
specifically to PR (82/94), compared to GR, where (5/94) interac-
tors were specific to GR, and (7/94) interactors were specific to both 
data sets. b STRING analysis was used to search for high-confidence-
known protein complexes amongst arginine-rich DPR interactors. 
Proteins depicted in red were specific to polyGR, proteins depicted 
in blue were specific to polyPR, and proteins depicted in purple were 
common to both data sets. Large numbers of ribosomal proteins were 
identified as binding to polyPR, as well as Rps3a which was found 
to bind to both polyGR and polyPR. c Top ten significantly over-
represented biological process gene ontology terms associated with 
proteins identified as binding polyPR and/or polyGR. Notably, cyto-
plasmic translation, translation and peptide biosynthetic process were 
significantly enriched categories (highlighted in bold) (P < 1E−10 for 
all)
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Expression of arginine‑rich dipeptide proteins 
suppresses translation in human iPSC‑derived 
motor neurons
The interaction of the arginine-rich DPRs with ribosomal 
subunits suggested that they might be capable of interfer-
ing with the process of translation. We, therefore, trans-
fected iPSC-derived motor neuron progenitors with plas-
mids encoding the N-terminally tagged arginine-rich DPR 
proteins GFP-GR100 and GFP-PR100 with GFP-GA100 or 
GFP alone as controls. We assessed translation by starv-
ing cells of methionine, and feeding them with a pulse of 
L-azidohomoalanine (AHA) 24 h after transfection with 
DPRs. Following fixation, a fluorescent label was covalently 
linked to the AHA-containing proteins, allowing assessment 
of the level of translation that had occurred. As expected, 
we observed robust incorporation and labelling of AHA in 
GFP-transfected cells, and this incorporation is prevented 
by the addition of the protein synthesis inhibitor anisomy-
cin (Fig. 2a). Furthermore, when we assessed the level of 
translation in cells expressing DPR constructs we found that, 
whilst GFP-GA100 had no effect on translational activity, 
both GFP-GR100 and GFP-PR100 strongly and significantly 
reduced translation in human neurons (Fig. 2a, b).
Expression of arginine‑rich dipeptide proteins 
suppresses translation in vivo
To determine whether translation was repressed in an in vivo 
model system, we adapted a recently published system for 
fluorescent non-canonical amino acid tagging (FUNCAT) in 
Drosophila [9]. This method is based on delivery of the non-
canonical amino acid Azidonorleucine (ANL), which can 
only be incorporated into nascent proteins in cells overex-
pressing the UAS-MetRSL262G methionyl-tRNA synthetase, 
with subsequent assessment of translation rates by fluores-
cently labelling the newly synthesised proteins with a tetra-
methyl rhodamine (TAMRA) tag using click-chemistry. We 
recombined the UAS-MetRSL262G-EGFP transgene with the 
elavGS driver, allowing inducible expression specifically in 
adult neurons. Insertions were backcrossed into the same 
wild-type stock (w1118) for six generations prior to the 
experiments, to ensure that observed differences were not 
due to genetic background. We additionally confirmed that 
flies expressing arginine-containing DPRs still displayed 
strong toxicity when expressing the UAS-MetRSL262G-
EGFP transgene (Suppl. Figure 5, Online Resource 1), 
whilst flies expressing polyGA had an intermediated lifes-
pan consistent with previous results [6, 28]. To avoid any 
differences in feeding behaviour affecting results, we directly 
injected a small volume of ANL into the haemolymph of 
flies 3 days after induction of expression, before performing 
dissection and FUNCAT labelling 48 h later. We observed 
a strong translation repression in flies expressing GR50, 
PR50 or 36 GGG GCC repeat (36R) constructs compared 
to controls, but not flies expressing GA50 (Fig. 3a,b). In 
addition, we also observed a significant reduction in the 
intensity of the  MetRSL262G-EGFP enzyme in these flies, 
(Fig. 3c). We confirmed that this is due to reduced abun-
dance of the  MetRSL262G-EGFP enzyme using western 
blotting in whole head lysates (Suppl. Figure 6, Online 
Resource 1). Despite this reduction, we did not observe a 
reduction in  MetRSL262G-EGFP transcript abundance by 
RT-qPCR (Fig. 3d), demonstrating that translation of the 
 MetRSL262G-EGFP enzyme was reduced as part of the trans-
lational repression induced by the arginine-rich DPRs, rather 
than a suppression of transgene expression per se, an effect 
that has been previously reported [32]. These results show 
that the arginine-containing DPRs suppress translation in 
neurons in vivo.
Eukaryotic initiation factor 1A expression rescues 
C9orf72 toxicity in Drosophila
We determined whether genetic interventions that could 
enhance translation can rescue toxic phenotypes associ-
ated with C9orf72 repeat RNA expression in vivo. We 
first attempted to rescue the lifespan phenotype previously 
reported in a 36 GGG GCC (36R) repeat-expressing Dros-
ophila model [28] by overexpressing factors potentially 
regulating translation. We carried out a mini-screen look-
ing at 70 ribosomal proteins and 11 translation initiation 
factors (available through the FlyORF library). These were 
individually expressed in adult Drosophila neurons co-
expressing 36R using the elavGS driver (Suppl. Figure 7, 
Online Resource 1). Lifespans were run in batches, always 
with a wild-type control. The lifespans were scored until 
the 30–40% of controls had died, so we would be able 
to identify both factors rescuing and enhancing toxicity. 
The total number of dead flies in each condition was then 
counted and expressed as a percentage relative to the con-
trol line. Seven candidates that showed a number dead 
that was < 30% of the control population were considered 
as rescuers. To rule out a genetic background effect, these 
stocks were rescreened after being backcrossed, and only 
a single protein, eukaryotic translation initiation factor 1A 
(eIF1A), which is essential for translation initiation [8], 
was able to reduce toxicity in flies expressing 36 repeats 
(Fig. 4a). This reduction in toxicity was not associated 
with reduced levels of the toxic GR protein (Fig. 4b), 
demonstrating that eIF1A overexpression did not affect 
RAN translation or polyGR clearance. Consistent with 
this, overexpression of eIF1A also partially rescued the 
lifespan defect observed in flies expressing GR100 in adult 
neurons (Fig. 4c). Consistent with a shared mechanism of 
toxicity, overexpression of eIF1A also extended lifespan in 
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PR100-expressing flies (Suppl. Figure 8a, Online Resource 
1). However, neuronal overexpression of eIF1A alone 
resulted in a modest shortening of lifespan, suggesting that 
eIF1A does not improve general neuronal health indepen-
dently of arginine rich-DPR expression (Suppl. Figure 8b, 
Online Resource 1). These results strongly implicate a 
conserved regulator of translation as a key modulator of 
the toxicity observed in an animal model of the C9orf72 
repeat expansion.
Eukaryotic initiation factor 1A expression rescues 
translation defects in cells expressing polyGR
We next sought to determine if overexpression of eIF1A 
enhances translation in polyGR-expressing cells. As 
the FUNCAT Drosophila system was not suitable (see 
discussion), we assessed translation in a simpler human 
cell model. We overexpressed GFP-GR100 in HeLa cells 
and again observed a strong reduction in translation using 
the AHA assay compared to controls expressing GFP 
alone (Fig. 5a, b). We cloned the human ortholog of eIF1A 
(EIF1AX) with an N-terminal FLAG tag. When human 
eIF1A is co-expressed, we observe a significant increase 
in translation compared to cells co-expressing GFP-
GR100 with FLAG alone (Fig. 5b). Although we observed 
an increased translation in eIF1A-expressing cells, we 
also observe a slight reduction in the GFP-GR100 signal 
(Fig. 5b), which may be responsible for this rescue (see dis-
cussion). Overall, these data implicate eIF1A, a potential 
inducer of translation, as a potent suppressor of GR toxicity 
in an in vivo model of C9orf72 repeat expansion toxicity 
and in human cells.
Fig. 2  Expression of arginine-
rich DPRs suppresses transla-
tion in human iPSC-derived 
MNs. a iPSC-MNs transfected 
to express DPRs (GFP-GA100, 
GFP-PR100, GFP-GR100) 
or GFP alone (arrow heads, 
green) were treated with AHA 
and newly synthesised proteins 
labelled with alkyne-tagged 
Alexa 555 (red), cells were 
counterstained with DAPI 
(blue). iPSC-MNs treated with 
100 µM of anisomycin and 
AHA for 2 h were used as a 
negative control for AHA imag-
ing (+Ani) and did not show 
incorporation of AHA (red). b 
AHA intensity was measured 
in DPR- or GFP-positive cells. 
Two inductions of control iPSC-
MNs were nucleofected, from 
which n = 44, 28, 43, 15 for 
GFP-, GA-, PR- or GR-positive 
iPSC-MNs, respectively, 
were analysed. Error bars are 
mean ± SEM. Kruskal–Wal-
lis test and Dunn’s Multiple 
comparison test, ***P < 0.001, 
ns indicates not significant
a
b
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Discussion
Here, we have identified DPR-interacting proteins specifi-
cally from intact brains of a Drosophila hexanucleotide 
repeat expansion model. We have identified translational 
factors, including ribosomal proteins as strongly enriched in 
our datasets. Meta-analysis of other recently produced data-
sets showed that ribosomal proteins are the most commonly 
identified interactors of the arginine-rich DPR proteins. We 
predicted that interaction with the arginine-rich DPRs would 
a b
Fig. 3  Expression of arginine-rich DPRs suppresses translation 
in Drosophila models. a Representative images showing expres-
sion of UAS-MetRSL262G-EGFP (green) as well as incorporation 
of ANL (red), DAPI is shown in blue. Scale bar = 5 μm b Quantifi-
cation of ANL incorporation (measured as intensity of TAMRA 
labelling) for each line. ANL incorporation was reduced compared 
to controls (w1118) in flies expressing GR50 (one way ANOVA 
P < 0.0001, ***P < 0.0001, Tukey’s multiple comparison test), 
PR50 (***P = 0.0003) and 36R (**P = 0.0011), but not GA50-
expressing flies (ns not significant, P = 0.9998). Translation was 
reduced compared to GA50-expressing flies in flies expressing GR50 
(***P < 0.0001), PR50 (***P = 0.0002), and 36R (***P = 0.0009). 
No significant differences were observed between GR50, PR50 and 
36R (ns not significant). Bars are mean ± SEM, points represent indi-
vidual brains (n = 7–10 per genotype). c  MetRSL262G-EGFP inten-
sity was reduced in flies expressing GR50, PR50 and 36R (one way 
ANOVA P < 0.0001, Dunnett’s test ***P = 0.0001), but not GA50 
(P = 0.1747). Bars are mean ± SEM, points represent individual 
brains (n = 7–10 per genotype). d RT-qPCR data demonstrated that 
transcript abundance of  MetRSL262G-EGFP was not significantly 
lower in flies expressing GR50 compared to controls (w1118) (ns not 
significant, P = 0.5188, two-tailed t test). Expression of EGFP was 
not observed in flies not carrying the  MetRSL262G-EGFP transgene 
(control). Bars are mean ± SEM, points represent individual samples 
(n = 4 for w1118 and GR50 samples, n = 3 for control). Genotypes: 
w; +; +/elavGS,  MetRSL262G-EGFP (w1118), w; +; UAS-GA50-
FLAG/elavGS,  MetRSL262G-EGFP (GA50), w; +; UAS-GR50-
FLAG/elavGS,  MetRSL262G-EGFP (GR50), w; +; UAS-PR50-FLAG/
elavGS,  MetRSL262G-EGFP (PR50), w; +/UAS-36R; +/elavGS, 
 MetRSL262G-EGFP (36R), w; +; +/TM3,sb (control)
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induce translational repression, and have observed this in 
both our Drosophila models in vivo as well as in HeLa cells 
and human iPSC-derived MNs. Further to this, we have 
demonstrated that overexpression of a key translational 
regulator can rescue the toxic phenotype observed in our 
Drosophila models. Together, these results strongly support 
the role of ribosomal dysfunction and translational repres-
sion in the pathogenesis of C9orf72-associated ALS/FTD.
Alterations in the control of protein translation have been 
strongly linked to neurodegeneration in number of contexts 
[17]. TDP-43 and FUS have both been linked to the forma-
tion of stress granules and disruption in localised synaptic 
translation [7]. In addition, translational defects have been 
linked to a number of ALS-associated diseases, including 
spinal muscular atrophy (SMA), where SMN protein has 
been demonstrated to interact with ribosomes, and its loss of 
function is implicated in inducing translational arrest, par-
ticularly in MNs [3, 35]. Additionally, impaired translation 
has been strongly implicated in the pathogenesis of Char-
cot–Marie–Tooth (CMT) peripheral neuropathies caused by 
dominant mutations in several aminoacyl-tRNA synthetases 
[32]. Finally, tau protein has been shown to bind to ribo-
somes in Alzheimer’s patient post-mortem tissue and sup-
press translation in vitro, implicating translational repression 
in tau-mutation-associated FTD [27].
Previous studies have demonstrated that expression of 
sense C9orf72 repeat RNA or exposure of cells to arginine-
rich DPRs is sufficient to induce a translational arrest, lend-
ing further support to our conclusion that translational arrest 
represents a key pathological mechanism in the disease state 
[16, 20, 34]. In other neurodegenerative disorders, such as 
Alzheimer’s and prion diseases, a potential mechanism of 
translational arrest is via the phosphorylation of Eif-2-al-
pha. However, others have shown that DPRs or repeat RNA 
expression was not sufficient to induce increased Eif-2-alpha 
phosphorylation [16, 34]. Thus, the mechanism by which 
translational repression is induced by the arginine-rich 
DPRs is undetermined, and has previously been suggested 
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Fig. 4  Overexpression of eIF1A rescues toxicity in Drosophila mod-
els independently of polyGR expression. a Lifespan of flies express-
ing 36 repeats alone (36R) or with the UAS-eIF1A transgene (36R; 
eIF1A) using the elavGS driver. Lifespan is significantly extended 
in flies expressing 36R with overexpression of eIF1A compared to 
36R alone (median lifespan 36R = 23.0  days, 36R; eIF1A = 28.0, 
*P = 1.15E − 16, log rank test). b Expression of polyGR was not 
reduced in flies expressing 36 repeats with eIF1A (36R; eIF1A) 
compared to 36 repeats alone (36R) (P = 0.8315, two-tailed t test, 
ns not significant). Bars are mean ± SEM (n = 4 samples per geno-
type). c Lifespan was significantly extended in flies expressing 
GR100 with overexpression of eIF1A (GR100; eIF1A) compared to 
GR100 alone (GR100) (median lifespan GR100 = 8.0  days, GR100; 
eIF1A = 10.5  days, *P = 9.35E−05, log rank test). Genotypes: w; 
UAS-36R/+; elavGS/+(36R), w; UAS-36R/+; elavGS/UAS-eIF1A 
(36R; eIF1A), w; UAS-GR100/+; elavGS/+ (GR100), w; UAS-
GR100/+; elavGS/ UAS-eIF1A (GR100; eIF1A)
Fig. 5  Overexpression of eIF1A reduces translational repression in 
human cells. a HeLa cells were transfected with plasmids encoding 
GFP alone (GFP), GFP-GR100 with a FLAG tag encoding vector, 
or GFP-GR100 with FLAG-tagged EIF1AX (GR100 + eIF1A). Pro-
tein synthesis was monitored using AHA (red), whilst expression of 
constructs was measured using GFP expression (green), and immu-
nostaining for FLAG (cyan), cells were counterstained using DAPI 
(blue). Individual example cells are circled (dotted lines). Scale 
bar = 20  µm. b Quantification of the average intensity of AHA per 
cell (box plot showing interquartile range with minimum and maxi-
mum values). Three independent experimental replicates are shown 
(Rep 1, Rep 2, Rep 3). A linear model was fitted to the data with tech-
nical covariate (day of the experiments) and treatment as fixed effects. 
We considered three pairwise comparisons between the three treat-
ment groups, controlling for multiple testing using Tukey’s post hoc 
procedure. Both GR100 and GR100 +eIF1A were highly significant 
compared to GFP (adjusted ***P < 10−10). GR100 + eIF1A also had 
a higher mean than GR100, with a more modest significance level 
(adjusted **P = 0.0011). c Quantification of the average intensity of 
GFP per cell (box plot showing interquartile range with minimum 
and maximum values). Three independent experimental replicates 
are shown (Rep 1, Rep 2, Rep3). Statistics were performed as in b. 
Three pairwise comparisons were performed between groups con-
trolling for multiple testing using Tukey’s post hoc procedure. Both 
GR100 and GR100 +eIF1A were highly significant compared to GFP 
(adjusted ***P < 10−10). GR100 + eIF1A had a higher mean than 
GR100 (***P = 0.0009). n (cells) total, GFP = 305, GR100 = 173, 
GR100 + eIF1A = 168
◂
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to be due to sequestration of translation initiation factors 
by repeat RNA [34], the direct binding of cellular mRNA 
by the arginine-containing DPRs [16], or the formation of 
cytoplasmic stress granules [20]. Whilst other mechanisms 
are conceivable, multiple studies have demonstrated interac-
tion between the arginine-rich DPRs and ribosomal proteins, 
even in the presence of RNAse (Suppl. Figure 4, Online 
Resource 1) [5, 16, 20, 22, 23, 45]. In this regard, it is nota-
ble that antimicrobial peptides enriched for PR-containing 
motifs have been demonstrated to bind to the ribosomal exit 
tunnel and inhibit bacterial protein synthesis [11]. In support 
of the ribosome-binding hypothesis, two studies, published 
after the submission of this article, demonstrate that overex-
pressed arginine-rich DPRs can inhibit protein synthesis [14, 
48]. Strikingly, both studies also identified ribosomal pro-
teins as constituents of polyGR inclusions found in patient 
brain tissue.
To try and rescue toxicity deriving from this translational 
defect, we screened 81 Drosophila overexpression lines from 
the FlyORF library. Flies have 79 different cytoplasmic ribo-
somal proteins [25]. Although we overexpressed the majority 
of these proteins, we failed to observe a rescue. This is likely 
due to the fact that ribosomal subunits are large, multi-pro-
tein complexes with complex stoichiometry, and thus over-
expressing one ribosomal protein would be unlikely to be 
able to lead to an increase in functional ribosomal subunits 
and, therefore, to an increase in translation. Flies have 43 
translation initiation factors, which have better characterised 
functions in the regulation of translation [24]. Of the ten that 
were available to us, one, eIF1A, a conserved component of 
the pre-initiation complex (PIC), led to a substantial rescue in 
phenotype when overexpressed. The only other component of 
the PIC we screened was part of eIF3, which is a large multi-
protein complex composed of at least ten non-identical subu-
nits, suggesting that upregulation of one component might 
not be enough to enhance its activity. It would be interesting, 
in future, to check whether upregulation of other PIC compo-
nents can also rescue the translation defect.
We predict that eIF1A directly alleviates the polyGR-
induced translation defect. However, with our current 
methodologies for measuring translation in vivo, we did 
not detect an increase in global translation in GR100 flies 
co-expressing eIF1A (data not shown). This is potentially 
because reduced translation of the  MetRSL262G-EGFP in 
polyGR-expressing flies makes it difficult to observe an 
enhanced translation. Alternatively, it may be because res-
cue of lifespan can be mediated by enhancing translation in 
only a subset of neurons, which would not be detected by 
our global staining approach. Consistent with possibility, 
DPR-driven toxicity has recently been shown to be selec-
tively toxic to a sub-population of neurons in flies [44]. In 
support of our proposed mechanism, we observed that over-
expression of eIF1A is sufficient to increase translation in 
human cells. However, in these cells there was a concomitant 
drop in GFP-GR100 expression, a phenomenon we did not 
observe in Drosophila. Thus, although it is likely that eIF1A 
overexpression increases translation in flies and human 
cells, we cannot rule out the possibility that eIF1A rescues 
C9orf72 repeat toxicity though a non-canonical mechanism 
not related to its primary function in translation.
In summary, we observe ribosomal proteins as key inter-
actors of the arginine-rich dipeptide proteins in an in vivo 
model of C9orf72-associated ALS and FTD. We have linked 
this to a translational repression both observable when argi-
nine-rich DPRs are expressed in HeLa cells, human iPSC-
derived MNs and in adult Drosophila neurons. Finally, we 
have identified overexpression of the translation initiation 
factor eIF1A as a key modifier of toxicity in our Drosophila 
models, further linking the observed translational repression 
to toxicity.
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